A window of opportunity for abatacept in RA: is disease duration an independent predictor of low disease activity/remission in clinical practice?

The objective of the study was to examine whether disease duration independently predicts treatment response among biologic-naïve patients with rheumatoid arthritis (RA) initiating abatacept in clinical practice. Using the Corrona RA registry (February 2006–January 2015), biologic-naïve patients wit...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Rheumatol
Auteurs principaux: Harrold, Leslie R., Litman, Heather J., Connolly, Sean E., Kelly, Sheila, Hua, Winnie, Alemao, Evo, Rosenblatt, Lisa, Rebello, Sabrina, Kremer, Joel M.
Format: Artigo
Langue:Inglês
Publié: Springer London 2017
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5486472/
https://ncbi.nlm.nih.gov/pubmed/28251392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10067-017-3588-7
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires